Lubiprostone Capsules, 8 mg an 24mg

Ascent Pharmaceuticals Inc

Revision date : 2025-05-21

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Version

00

Revision date

2025-05-21

Product name

Lubiprostone Capsules, 8 mg an 24mg

Product Synonyms

Not found

CAS No.

333963-40-9

Emergency telephone

1-855-221-1622

Icons in SDS

M004 M009 M010 M017

Company Information

company name

Ascent Pharmaceuticals Inc

Section 2

SECTION 2: Hazards identification

Not considered hazardous when handled under normal conditions. Accidental ingestion of large amounts may be harmful.

2.1 Classification of the substance or mixture

Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions Not classified

2.2 Label elements

Not classified

2.3 Other hazards

Exposure may aggravate pre-existing eye, skin, or respiratory conditions. Unknown acute toxicity: No information available

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.